ロード中...
Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency (SCID) Patients: a Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT
Severe Combined Immunodeficiency (SCID) is one of the most common indications for pediatric hematopoietic cell transplantation (HCT) in patients with primary immunodeficiency (PID). Historically, SCID was diagnosed in infants who presented with opportunistic infections within the first year of life....
保存先:
| 出版年: | Biol Blood Marrow Transplant |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2017
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5659271/ https://ncbi.nlm.nih.gov/pubmed/28068510 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2016.12.619 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|